Small-cap Healthcare company Cronos has logged a -3.8% change today on a trading volume of 1,019,686. The average volume for the stock is 1,881,458.
Cronos Group Inc. operates as a cannabinoid company. Based in Toronto, Canada the company has 626 full time employees and a market cap of $1,108,192,640. The company is now trading -30.1% away from its average analyst target price of $4.17 per share. The 9 analysts following the stock have set target prices ranging from $2.65 to $7, and on average give Cronos a rating of hold.
Over the last year, CRON shares have gone down by -34.1%, which represents a difference of -18.0% when compared to the S&P 500. The stock's 52 week high is $4.73 per share and its 52 week low is $2.57. With its gross margins declining an average -53.9% over the last four years, Cronos may not have a strong enough business to reverse this trend.